LANGUAGE:
LANGUAGE:
Our people are our pride, helping companies resonate with their customers for 20+ years.
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Solutions
Our experts know the in-and-outs of your industry & its challenges.
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Our people are our pride, helping companies resonate with their customers for 20+ years.
About Us
Key Facts
Leadership
Insights
News
Trust Center
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Content Services
Technical Writing
Training & eLearning
Financial Reports
Multicultural Marketing
Digital Experience Assessments
Translation Services
Translation
Video Localization
Software Localization
Website Localization
Translation for Regulated Companies
Interpretation
Multilingual SEO & Digital Marketing
Content Optimization
Testing Services
Functional QA & Testing
Compatibility Testing
Interoperability Testing
Performance Testing
Accessibility Testing
UX/CX Testing
Solutions
Digital Marketing
Live Events
Machine Translation
Our Knowledge Hubs
Future of Localization
Innovation to Immunity
COVID-19 Resource Center
Disruption Series
Patient Engagement
Lionbridge Insights
Our experts know the in-and-outs of your industry & its challenges.
Life Sciences
Banking & Finance
Retail
E-Commerce
Games
Automotive
Consumer Packaged Goods
Technology
Industrial Manufacturing
Legal Services
Travel & Hospitality
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Lainguage Cloud™ Platform
Connectivity
Translation Community
Workflow Technology
Smairt Content™
Smairt MT™
Smairt Data™
Language Quality
Analytics
SELECT LANGUAGE:
人类的好奇心和探索热情推动了频繁的创新。全世界现在都屏息期待 mRNA 技术和“缺陷型”黑猩猩腺病毒的创新应用能够对受新冠肺炎疫情影响的人群提供免疫力。
在过去 25 年中,Lionbridge 一直与制药公司合作,帮助他们安全地交付药物并推广到全球市场。我们在药品和医疗器械的研发、注册、营销和生命周期管理过程中,帮助您触及全球市场并与监管机构、研究人员、医疗专业人员、患者和用户建立联系。
您负责研发治病救人的药物,提升全球健康水平。而我们的职责就是为您处理好各种内容,帮助您以安全、准确、高效的方式向全世界传达信息、交付产品。
本中心为从事临床试验、监管或市场营销方面的专业人员提供建议,帮助他们将创新想法转化为免疫实践、将启发转化为见解,进而指导他人应对本次疫情。我们的专家还分享了在临床试验、疫苗的临床和监管流程、疫苗分销和接受度等方面的多种见解。
Lionbridge 生命科学专家将一如既往地分享各类知识和技能。我们关于新冠肺炎疫苗的系列文章汇集了 Mark Aiello、Pia Windelov 以及 Nataliya Volohov 等一众领导者对此开创性工作的观点。
让我们的团队与您倾力合作,将敏感、复杂且时常变化的内容转变为能够与全球每位最终用户产生共鸣的文字,帮助您与监管机构、医疗服务提供商以及患者妥善沟通。联系我们,与经验丰富的专家交流,了解我们如何为您提供支持。